With respect to tumor-specific T-cell responses, we did not observe reductions in the frequency of neoantigen-specific CD8+ T cells either in the spleens or tumors of S47 mice, suggesting that there are no overt deficits in priming or trafficking of S47 T cells specific for MC38-derived neoantigens. The gene discussed is CD8A; the disease is neoplasm.